227 related articles for article (PubMed ID: 28402947)
41. STEAP3 promotes colon cancer cell proliferation and migration via regulating histone acetylation.
Lv J; Liu X; Sun Z; Gao J; Yu X; Zhang M; Zhang Z; Ren S; Zuo Y
Hum Genet; 2024 Mar; 143(3):343-355. PubMed ID: 38480539
[TBL] [Abstract][Full Text] [Related]
42. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer.
Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J
Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912
[TBL] [Abstract][Full Text] [Related]
43. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.
Gilchrist M; Thorsson V; Li B; Rust AG; Korb M; Roach JC; Kennedy K; Hai T; Bolouri H; Aderem A
Nature; 2006 May; 441(7090):173-8. PubMed ID: 16688168
[TBL] [Abstract][Full Text] [Related]
44. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
45. Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway.
Yamaguchi K; Lee SH; Kim JS; Wimalasena J; Kitajima S; Baek SJ
Cancer Res; 2006 Feb; 66(4):2376-84. PubMed ID: 16489044
[TBL] [Abstract][Full Text] [Related]
46. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
47. The Expression Profile and Prognostic Significance of Metallothionein Genes in Colorectal Cancer.
Hung KC; Huang TC; Cheng CH; Cheng YW; Lin DY; Fan JJ; Lee KH
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394742
[TBL] [Abstract][Full Text] [Related]
48. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
49. Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells.
Lu X; Zhong L; Lindell E; Veanes M; Guo J; Zhao M; Salehi M; Swartling FJ; Chen X; Sjöblom T; Zhang X
Cell Death Dis; 2023 Oct; 14(10):676. PubMed ID: 37833290
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.
Zhang J; Deng Y; Zuo Y; Wang J; Zhao Y
DNA Cell Biol; 2020 Jan; 39(1):16-24. PubMed ID: 31808724
[TBL] [Abstract][Full Text] [Related]
51. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
52. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
53. ATF3-CBS signaling axis coordinates ferroptosis and tumorigenesis in colorectal cancer.
Liu J; Lu X; Zeng S; Fu R; Wang X; Luo L; Huang T; Deng X; Zheng H; Ma S; Ning D; Zong L; Lin SH; Zhang Y
Redox Biol; 2024 May; 71():103118. PubMed ID: 38490069
[TBL] [Abstract][Full Text] [Related]
54. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
[TBL] [Abstract][Full Text] [Related]
55. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
[TBL] [Abstract][Full Text] [Related]
56. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
57.
Peng L; Chang J; Liu X; Lu S; Ren H; Zhou X; Liu Z; Hu P
Curr Issues Mol Biol; 2021 Oct; 43(3):1529-1547. PubMed ID: 34698109
[TBL] [Abstract][Full Text] [Related]
58. CILP2 is a potential biomarker for the prediction and therapeutic target of peritoneal metastases in colorectal cancer.
Ha YJ; Park SH; Tak KH; Lee JL; Kim CW; Kim JH; Kim SY; Kim SK; Yoon YS
Sci Rep; 2024 May; 14(1):12487. PubMed ID: 38816545
[TBL] [Abstract][Full Text] [Related]
59. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
